Distinguished in Pyomyositis

Dimitri Ceroni

Geneve, GE, CH 
Distinguished in Pyomyositis
Geneve, GE, CH 
OverviewLocationsClinical Research

Overview

Dimitri Ceroni practices in Geneve, Switzerland. Mr. Ceroni is rated as a Distinguished expert by MediFind in the treatment of Pyomyositis. His top areas of expertise are Osteomyelitis in Children, Osteomyelitis, Septic Arthritis, Infectious Arthritis, and Osteotomy.

His clinical research consists of co-authoring 132 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Pyomyositis.

Gender
Male

Locations

Geneve, GE 1211, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

132 Total Publications

Comparison of clinical and biological data between septic arthritis of the hip and those of the knee caused by Kingella kingae.
Comparison of clinical and biological data between septic arthritis of the hip and those of the knee caused by Kingella kingae.
Journal: Journal of pediatric orthopedics. Part B
Published: August 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ceroni's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile